MENU
MURA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mural Oncology (MURA) Ownership - Who owns Mural Oncology?
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more
Profile
Industry
N/A
Address
10 Earlsfort Terrace
Phone
+353 19058020
Employees
117
Web
https://www.muraloncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
62.78M
P/E Ratio
N/A
Total Cash
175.5M
Projected Growth
N/A
Total Debt
9.55M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
10.29
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MURA
Capitalization
62.8M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
176M
Total Cash/Share
10.29
Total Debt
9.55M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
174M
P/B Ratio
0.36
Cash Flow
N/A
Earnings
-9.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
170K
Current Ratio
7.38
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-157.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-131.73
Shares Held By Institutions
31.7M
Shares Outstanding - Current
17.1M
Total Liabilities
29.1M
Total Volume MTD
N/A
Value
1
Gain YTD
14.286
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
10 Earlsfort Terrace
Phone
+353 19058020
Employees
117
Web
https://www.muraloncology.com